Short answer

Designers and manufacturers can explore inkjet 3D printing with specialized bioinks for creating customized pharmaceutical products, moving towards more personalized healthcare solutions.

Field: Commercial Production
Source: Bioengineering (2017)
Method: Experimental design and characterization
Evidence: Strong effect

A photocurable bioink formulation allows for the precise, on-demand printing of pharmaceutical tablets with tailored drug dosages. This commercial production research insight is drawn from a 2017 study published in Bioengineering. Using Experimental design and characterization, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Designers and manufacturers can explore inkjet 3D printing with specialized bioinks for creating customized pharmaceutical products, moving towards more personalized healthcare solutions.

Study

Commercial ProductionHigh ImpactStrong effect

Inkjet 3D Printing Enables Rapid Customization of Pharmaceutical Dosage Forms

A photocurable bioink formulation allows for the precise, on-demand printing of pharmaceutical tablets with tailored drug dosages.

Bioengineering · 2017

Key Findings

01A biocompatible, photocurable bioink was successfully designed for inkjet 3D printing.
02The bioink facilitated the rapid printing and polymerization of pharmaceutical tablets.
03Printed tablets demonstrated a rapid drug release profile, with 60% released within 15 minutes of dissolution.

Application

Design takeaway

Designers and manufacturers can explore inkjet 3D printing with specialized bioinks for creating customized pharmaceutical products, moving towards more personalized healthcare solutions.

How to apply

Consider developing custom-formulated, 3D-printed products for niche markets where personalization and on-demand production are critical, such as specialized medical devices or tailored consumer goods.

Project actions

01When designing for personalized products, consider how additive manufacturing can enable customization.
02Investigate material properties that allow for rapid curing or setting in your chosen manufacturing process.

Method & Evidence

AimCan a photocurable bioink be developed for inkjet 3D printing to enable the rapid, customized production of pharmaceutical tablets for hydrophilic drugs?

MethodExperimental design and characterization

ProcedureHyaluronic acid was modified with norbornene groups and combined with polyethylene glycol dithiol and a photoinitiator. This bioink was then loaded with a hydrophilic drug (Ropinirole HCl) and printed onto a preform tablet using a piezoelectric inkjet nozzle. The printed tablet was then polymerized using visible light, and its drug release profile was analyzed.

ContextPharmaceutical manufacturing, personalized medicine, 3D printing

Variables

IVBioink formulation (e.g., functionalized hyaluronic acid, crosslinker, photoinitiator)

DVDrug release rate, printability, polymerization speed

CVType of drug (hydrophilic), printing nozzle type (piezoelectric), light source, preform tablet material

Strengths & Limitations

Strengths

+Successful development of a novel photocurable bioink.
+Demonstration of rapid drug release from printed tablets.

Limitations

The complexity of pharmaceutical regulations means that direct application of this technology to human medicine requires extensive further research and approval.

Reliability & validity

The study's findings are supported by experimental data on drug release and material characterization. Reliability would depend on the reproducibility of the bioink synthesis and printing process.

Think critically

What are the ethical considerations and potential societal impacts of widely adopting personalized, 3D-printed pharmaceuticals?

Design Principles

"Leverage additive manufacturing and tailored material formulations to achieve on-demand, personalized product creation."

This advancement in 3D printing technology offers a pathway to personalized medicine by enabling the rapid, localized manufacturing of medications. It addresses the need for customized drug delivery, potentially improving patient outcomes and reducing waste associated with mass production of standardized dosages.

What This Means for Your Design

This study shows that we can use a special 3D printer ink to make custom medicine tablets very quickly. This could mean getting the exact medicine dose you need, when you need it.

How to use in your project

1.This research can be cited to support the use of additive manufacturing for creating customized products, particularly in fields like healthcare or specialized consumer goods.

Add to My Project

Quick Cite

Paragraph starter

The development of photocurable bioinks for inkjet 3D printing, as demonstrated by Acosta‐Vélez et al. (2017), offers a significant advancement in the on-demand production of personalized pharmaceutical dosage forms. This research highlights the potential for rapid, customized manufacturing, moving beyond traditional mass-production models.

Source

Bioengineering

Photocurable Bioink for the Inkjet 3D Pharming of Hydrophilic Drugs

journal · 2017

View source

Questions About This Research

What does the research say about inkjet 3d printing enables rapid customization of pharmaceutical dosage forms?: Designers and manufacturers can explore inkjet 3D printing with specialized bioinks for creating customized pharmaceutical products, moving towards more personalized healthcare solutions. Evidence: Bioengineering (2017).
Why does "Inkjet 3D Printing Enables Rapid Customization of Pharmaceutical Dosage Forms" matter for design?: This advancement in 3D printing technology offers a pathway to personalized medicine by enabling the rapid, localized manufacturing of medications. It addresses the need for customized drug delivery, potentially improving patient outcomes and reducing waste associated with mass production of standardized dosages.
How can designers apply this research?: Designers and manufacturers can explore inkjet 3D printing with specialized bioinks for creating customized pharmaceutical products, moving towards more personalized healthcare solutions.
What were the main findings?: A biocompatible, photocurable bioink was successfully designed for inkjet 3D printing.. The bioink facilitated the rapid printing and polymerization of pharmaceutical tablets.. Printed tablets demonstrated a rapid drug release profile, with 60% released within 15 minutes of dissolution.
What research method was used?: Experimental design and characterization.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2017 journal from Bioengineering.
What should I do differently in my next project?: Consider developing custom-formulated, 3D-printed products for niche markets where personalization and on-demand production are critical, such as specialized medical devices or tailored consumer goods.
What are the limitations?: The study focused on a single hydrophilic drug and a specific bioink formulation; further research is needed to explore a wider range of APIs and bioink compositions. Long-term stability and regulatory approval for 3D-printed pharmaceuticals would require extensive investigation.